Unravelling underrepresented immune cell complexity in MS

Dr Belinda Kaskow

CMMIT Murdoch University, Perron Institute, The University of Western Australia, WA

| Causes and Prevention | Immunology | Incubator | 2024 | Investigator Led Research |
SUPPORT PROJECTS WITH THIS RESEARCH FOCUS

Summary

The immune system is finely balanced to allow for strong immune responses against foreign antigens (e.g. viruses) but controlled so that self-antigens do not trigger an immune response. In MS, the immune system is dysregulated, leading to immune attacks on self-antigens in the brain and spinal cord. Killer immunoglobulin-like receptors (KIRs) are found on certain immune cells and help control immune responses. However, the KIR family is highly complex and variable among individuals making it challenging to study using traditional methods.

This project will investigate KIR expression from multiple levels, including which genes are present in an individual, when those genes are expressed and what cell types express them. It will compare this between people living with MS and people living without MS to understand the differences in the KIR repertoire in MS.

To date, the available technology has limited the study of KIRs, but recent advances in the understanding of the complexity of KIR and the development of innovative approaches will allow Dr Kaskow and her team to comprehensively characterise KIR expression and elucidate of the role of KIR in MS. Understanding how KIR impacts the balance of the immune system in MS will lead to better, more targeted immunotherapies for MS in the future.

Updated: 22 January, 2024

Stages of the research process

Fundamental laboratory
Research

Laboratory research that investigates scientific theories behind the possible causes, disease progression, ways to diagnose and better treat MS.

Lab to clinic timeline: 10+ years
Translational
Research

Research that builds on fundamental scientific research to develop new therapies, medical procedures or diagnostics and advances it closer to the clinic.

Lab to clinic timeline: 5+ years
Clinical Studies
and Clinical Trials

Clinical research is the culmination of fundamental and translational research turning those research discoveries into treatments and interventions for people with MS.

Lab to clinic timeline: 1-5 years

Investigator

Dr Belinda Kaskow

Co-investigator

  • Professor Allan Kermode
  • Associate Professor Silvana Gaudieri
  • Associate Professor Abha Chopra
  • Dr Pooja Desphande
  • Mr Eric Alves
  • Ms Milan Pietracatella

Total Funding

  • $25,000

Duration

  • 1 year – starting 2024

Read More

Newsletter subscription

  • Enter your details

Unravelling underrepresented immune cell complexity in MS